In animal models, Reta has consistently improved glucose handling, with treated subjects demonstrating enhanced glucose tolerance during oral glucose tolerance tests (OGTTs)
Vitamin D correction with high-dose supplementation (50,000 IU weekly for eight to twelve weeks, then maintenance dosing) can normalize levels within three months
Semaglutide is a well-known GLP-1 receptor agonist
Marti-Aguado D, Calleja JL, Vilar-Gomez E, Iruzubieta P, Rodrguez-Duque JC, Del Barrio M, Puchades L, Rivera-Esteban J, Perell C, Puente A, Gomez-Medina C, Escudero-Garca D, Serra MA, Bataller R, Crespo J, Arias-Loste MT
Studies directly characterizing the effects of treatment with tirzepatide in patients with T2D and/or obesity and COVID-19 or long COVID have not been published yet